NTRA
Natera Inc
NASDAQ · Biotechnology
$203.04
+5.96 (+3.02%)
Performance
1D
—
1W
-12.14%
1M
-13.77%
3M
-1.78%
6M
+28.75%
1Y
+17.92%
YTD
-11.27%
Open$199.73
Previous Close$197.08
Day High$203.68
Day Low$194.02
52W High$256.36
52W Low$125.38
Volume1.55M
Avg Volume1.17M
Market Cap28.08B
P/E Ratio—
EPS$-2.28
SectorBiotechnology
Volume Analysis
1.32x average volume
Technical Indicators
SMA 50
$233.64
Below
SMA 200
$184.08
Above
RSI (14)
27.8
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-29.6% upside
Current
$203.04
$203.04
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 1.88B | 1.35B | 5.49B |
| Net Income | -211,202,554 | -136,289,021 | 1.03B |
| Profit Margin | -11.2% | -10.7% | 18.8% |
| EBITDA | -212,198,466 | -144,538,999 | 1.33B |
| Free Cash Flow | — | — | 838.86M |
| Rev Growth | +39.5% | +39.5% | +5.0% |
| Debt/Equity | 0.07 | 0.07 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |